84. サルコイドーシス Sarcoidosis Clinical trials / Disease details


臨床試験数 : 149 薬物数 : 227 - (DrugBank : 81) / 標的遺伝子数 : 82 - 標的パスウェイ数 : 167

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2017-004219-37-DE
(EUCTR)
16/03/202129/07/2020Influence of Inhaled Aviptadil on Cough and Quality of life in SarcoidosisA randomized, prospective, multicenter, controlled and double-blinded Phase II Clinical Trial to evaluate the influence of inhaled Aviptadil on Cough and Quality of Life in Sarcoidosis patients - Avisarco II Pulmonary sarcoidosis associated with cough
MedDRA version: 20.0;Level: PT;Classification code 10037430;Term: Pulmonary sarcoidosis;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Product Name: Aviptadil
INN or Proposed INN: Aviptadil
Other descriptive name: AVIPTADIL
Universitätsklinikum Freiburg, Leitender Ärztlicher DirektorUniversitätsklinikum Freiburg, Kaufmännische DirektorinAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
200Phase 2Germany